Hensley Evans of ZS Associates drops in to discuss her new book on patient-centricity, and why pharma is taking so long to put patients at the forefront.
‘MasterChef’ champ and blind cook Christine Ha fronts Horizon campaign
Craig Martin, CEO of rare disease advocacy group Global Genes, explains the perils and pitfalls to the patient-led revolution around rare disease therapeutics.
While battling ALS, she fought to change the way biotech allows access to experimental drugs. In doing so, she not only drew more attention to the disease, but also broke barriers to expanded access.
‘It should’ve been an easy diagnosis’: Inside Grace Anne Dorney Koppel’s COPD battle and advocacy